OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
March 17, 2025 08:00 ET | Source: OPKO Health, Inc. MIAMI and…
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ --…
Axtria Ignite 2025: Annual Conference to Focus on Shaping Leadership in an Agentic Era for Life Sciences
Next-Gen Therapies and Data-Driven Innovation Take Center Stage as Industry Leaders Explore…
Amaran Biotech Signs MOU with Nippon Fine Chemical
TAIPEI, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Amaran Biotechnology Inc., a…
Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage…
LinkGevity Awarded Innovate UK Smart Grant for Anti-NecroticResearch to Prevent Kidney Deterioration
March 04, 2025 04:00 ET | Source: LinkGevity LONDON, March 04, 2025…
Derm-Biomes DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc,…
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
--- The United States FDA Approves the Initiation for Phase II Efficacy…
Tevogen Bios First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
600% higher market cap per team member when compared to industry average.…
BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion
- Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named…